Dimopoulos, M.A. Lonial, S. Betts, K.A. Chen, C. Zichlin, M.L. Brun, A. Signorovitch, J.E. Makenbaeva, D. Mekan, S. Sy, O. Weisel, K. Richardson, P.G., Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 4-year follow-up and analysis of relative progression-free survival from the randomized ELOQUENT-2 trial, JMIR Cancer, (124), 4032-4043, 2018, John Wiley and Sons Inc,